[Form 4] Xylem Inc Insider Trading Activity

Rhea-AI Filing Summary

Insider sale by Xylem director. A director of Xylem Inc. reported selling 4,900 shares of the company's common stock on 08/18/2025 at a weighted average price of $140.6594 per share. After the sale the reporting person beneficially owns 5,163 shares. The filing discloses that the 4,900 shares were sold across a price range of $140.43 to $140.86 and that the reporting person will provide details of the number of shares sold at each price upon request.

Insights

Corporate Governance Expert

TL;DR: A director executed a modest sale reducing her stake to just over 5,000 shares; disclosure appears complete and routine.

The Form 4 shows an open-market sale by a director for 4,900 shares at a weighted average of $140.6594. The report includes a customary explanatory note about execution across a price range and an offer to provide per-price execution details on request, which supports transparency. The remaining beneficial holding of 5,163 shares is small relative to typical director ownership levels, suggesting limited ongoing economic exposure. No derivatives, grants, or acquisitions are reported.

Securities Analyst

TL;DR: Director sale is disclosed clearly; transaction size is modest and unlikely to be materially market-moving.

The transaction code indicates an open-market sale of 4,900 shares at a weighted average price of $140.6594, executed across $140.43–$140.86. The Form 4 lists only non-derivative shares disposed and shows 5,163 shares remaining beneficially owned. From an investor-materiality perspective, the sale is routine and the filing contains the required execution-range disclosure. There is no indication of rule 10b5-1 reliance in the checked boxes.

Insider Trade Summary

Net Seller: 4,900 shares ($689,231)

Net Sell 1 txn

Insider Glatch Lisa

Role Director

Sold 4,900 shs ($689K)

Type	Security	Shares	Price	Value
Sale	Common Stock	4,900	$140.6594	$689K

Holdings After Transaction: Common Stock — 5,163 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Glatch Lisa

(Last) (First) (Middle)

C/O XYLEM INC.

301 WATER STREET SE

(Street)

WASHINGTON DC 20003

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/18/2025		S		4,900	D	$140.6594(1)	5,163	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,900 Shares were executed at a range of prices from $140.43 to $140.86. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

Remarks:

	/s/ Mike Nazario, by power of attorney for Lisa Glatch	08/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.